Article Correctness Is Author's Responsibility: Tumor-Promoting Immune Cells Retrained to Fight Most Aggressive Type of Brain Cancer

The article below may contain offensive and/or incorrect content.

This shows a picture of a brain with someone's finger on itCombining αGITR antibodies with ICBs resulted in stronger survival benefits in mouse models of human glioblastoma brain cancer.